B. Telek

发表

Abstract

K. Laczika, C. Marosi, D. Fuchs, 2005, Annals of Hematology.

HODGKIN'S DISEASE AND MEMORY LOSS: ANOTHER CASE OF THE OPHELIA SYNDROME

B. Telek, K. Rák, G. Pfliegler, 1990, British journal of haematology.

Abstract

Shawnta S. Friday-Stroud, Earnest Friday, Anna L. Green, 2005, Annals of Hematology.

Megakaryocyte markers in myeloproliferative disorders.

B. Telek, J. Iványi, I. Tornai, 1993, Acta histochemica.

Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.

B. Telek, K. Rák, G. Ujj, 1998, Thrombosis research.

Successful control of massive coumarol-induced acute upper gastrointestinal bleeding and correction of prothrombin time by recombinant active factor VII (Eptacog-alpha, NovoSeven) in a patient with a prosthetic aortic valve and two malignancies (chronic lymphoid leukaemia and lung cancer).

B. Telek, I. Altorjay, M. Udvardy, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[Transformation of chronic lymphocytic leukemia to myelodysplastic syndrome: case presentation and review of the literature].

B. Telek, L. Méhes, M. Udvardy, 2009, Orvosi hetilap.

Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase.

J. Kónya, Z. Beck, E. Csoma, 2003, European journal of cancer.

[Treatment of acute myeloid leukemia -- a single center experience (2007-2013)].

Á. Illés, R. Szász, B. Telek, 2014, Orvosi Hetilap.

[Mantle cell lymphoma: case report].

B. Telek, L. Méhes, M. Udvardy, 2008, Orvosi hetilap.

Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia, Focusing on Long Term Cytopenias Before and After the Era of Targeted Therapies

Á. Illés, R. Szász, B. Telek, 2021, Pathology & Oncology Research.

Differential diagnostic value of acid phosphatase and beta-glucuronidase in acute leukaemia

B. Telek, K. Rák, A. Kiss, 1983, Blut: Zeitschrift für die Gesamte Blutforschung.

Chromosomal aberrations and CD38 expression in two siblings with B-cell chronic lymphocytic leukemia: A report of two siblings

B. Telek, M. Balázs, L. Méhes, 2005, Leukemia & lymphoma.

Abstract

K. Laczika, C. Marosi, D. Fuchs, 1984, Veterinary Record.

A Case of Therapy-related Acute Myeloid Leukemia Following Treatment with 5-Fluorouracil

Á. Illés, B. Telek, S. Molnár, 2018, Cureus.

[Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol].

B. Telek, M. Udvardy, P. Batár, 2010, Orvosi hetilap.

[Practical considerations and questions in the treatment of chronic lymphocytic leukemia].

R. Szász, B. Telek, M. Udvardy, 2011, Orvosi hetilap.

Advanced and Terminal Phase of B-Cell Chronic Lymphocytic Leukemia

B. Telek, K. Rák, A. Kiss, 1993 .

"Pros and Cons" on How to Measure Multidrug Resistance in Leukemias

B. Telek, J. Kappelmayer, É. Karászi, 2002, Leukemia & lymphoma.

Nucleolar organizer regions in acute and chronic leukaemias.

B. Telek, J. Iványi, A. Kiss, 1992, Acta histochemica.

Platelet function studies in myeloproliferative disorders.

B. Telek, K. Rák, P. Nagy, 1986, Folia haematologica.

[Current treatment of acute myeloid leukaemia in adults].

R. Szász, B. Telek, M. Udvardy, 2012, Orvosi hetilap.

Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia

G. Szakács, B. Sarkadi, L. Homolya, 2001, British journal of haematology.

SEX‐LINKED DIFFERENCE IN BLOOD‐GROUP DISTRIBUTION AMONG PATIENTS SUFFERING FROM ACUTE LEUKAEMIAS

B. Telek, K. Rák, J. Jákó, 1981, British journal of haematology.

Factor XIII of Blood Coagulation in Malignant Hematological Diseases

R. Ádány, S. Berkessy, B. Telek, 2019, Hemostasis and Cancer.

Co-expression of c-abl and c-myb oncogenes in Philadelphia chromosome-negative, bcr-negative chronic myeloid leukaemia.

F. Tóth, J. Kiss, B. Telek, 1994, Leukemia research.

[Successful alemtuzumab treatment of a patient with atypical hairy cell leukaemia variant].

B. Telek, M. Udvardy, P. Batár, 2007, Orvosi hetilap.

[Diagnosis of megakaryoblastic leukemia].

R. Ádány, B. Telek, K. Rák, 1989, Folia haematologica.

Behçet's disease in a patient with myelodysplastic syndrome.

B. Telek, H. Németh, G. Pfliegler, 2009, Clinical lymphoma & myeloma.

Use of a platelet filter test in patients with thrombocytosis.

A. Kiss, B. Telek, Á. Schlammadinger, 2000, Platelets.

Alterations of P53 and RB Genes and the Evolution of the Accelerated Phase of Chronic Myeloid Leukemia

Á. Borbély, Z. Beck, A. Bácsi, 2000, Leukemia & lymphoma.

Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration.

Z. Beck, E. Kovács, A. Bácsi, 1998, Leukemia & lymphoma.

P. Surányi, F. Tóth, J. Kiss, 1992, Leukemia research.

Histocompatibility antigens in hairy cell leukaemia.

B. Telek, J. Demeter, K. Pálóczi, 1989, Tissue antigens.

The addition of bortezomib to induction therapy of refractory adultory AML, preliminary results

R. Szász, A. Kiss, B. Telek, 2009 .

[Involvement of the central nervous system in non-Hodgkin's lymphoma].

B. Telek, K. Rák, A. Kiss, 1986, Orvosi hetilap.

Identification of NPMc+ Acute Myeloid Leukemia in Bone Marrow Smears

B. Telek, G. Méhes, Z. Hevessy, 2012, Applied immunohistochemistry & molecular morphology : AIMM.

Detection of main core proteins of simian C-type viruses and human retrovirus HTLV and antibodies to them in patients with lymphoid malignancies.

F. Tóth, J. Kiss, B. Telek, 1985, Acta microbiologica Hungarica.

[Effective PAD (bortezomib, doxorubicin, dexamethasone) treatment of a patient with plasma cell leukaemia that has developed after autologous stem cell transplantation].

B. Telek, L. Méhes, M. Udvardy, 2008, Orvosi hetilap.